Treatment and prevention of pain due to vaso-occlusive crises in adults with sickle cell disease: An educational void

Blood

Volumn 111, Issue 3, 2008, Pages 997-1003

  Solomon, Lawrence R ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROMORPHONE; HYDROXYUREA; MORPHINE; OPIATE;

ADDICTION; ANALGESIA; ARTICLE; CANCER PAIN; EMERGENCY CARE; EVIDENCE BASED MEDICINE; HEMATOLOGIC DISEASE; HOSPITAL CARE; HUMAN; LOADING DRUG DOSE; MEDICAL RESEARCH; PAIN; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRACTICE GUIDELINE; PRIORITY JOURNAL; SICKLE CELL ANEMIA; SUBSTANCE ABUSE; TREATMENT PLANNING;

EID: 38949178118     PISSN: 00064971     EISSN: 00064971     Source Type: Journal    
DOI: 10.1182/blood-2007-07-089144     Document Type: Article

References (62)

1. Steiner CA, Miller JL. Sickle cell disease patients in US hospitals 2004. HCUP Statistical Brief no. 21. December, 2006.
2. Benjamin LJ, Dampier CD, Jacox AK, et al. Guideline for the management of acute and chronic pain in sickle-cell disease. APS Clinical Practice Guideline Series, No. 1, 1999; Glenville, IL.
3. Rees DC, Olujohunghe AD, Parker NE, Stephens AD, Telfer P, Wright J. Guidelines for the management of the acute painful crisis in sickle cell disease. Brit J Haematol. 2003;120:744-752.
4. National Institutes of Health. The Management of Sickle Cell Disease. 4th ed. Bethesda, MD: National Heart, Lung, and Blood Institute; 2002:59-74. NIH Publication 02-2117.
5. Booker MJ, Blethyn KL, Wright CJ, Greenfield SM. Pain management is sickle cell disease. Chronic Illn. 2006;2:39-50.
6. Charache S, Terrin ML, Moore RD, et al. Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. N Engl J Med. 1995;332:1317-1322.
7. Zumberg MS, Reddy S, Boyette RL, Schwartz RJ, Konrad TR, Lottenberg R. Hydroxyurea therapy for sickle cell disease in community-based practices: a survey of Florida and North Carolina hematologists/oncologists. Am J Hematol. 2005;79:107-113.
8. Lanzkron S, Haywood C, Segal JB, Dover GJ. Hospitalization rates and cost of care of patients with sickle-cell anemia in the state of Maryland in the era of hydroxyurea. Am J Hematol. 2006;81:927-932.
9. Greer JP, Foerster J, Lukens JN, et al. 11th ed. Philadelphia PA: Lippincott Williams & Wilkins; 2004.
10. Hoffman R, ed. Hematology: Basic Principles and Practice. 4th ed. Philadelphia PA: Elsevier Churchill Livingston; 2005.
11. Lichtman MA, Beutler E, Kripps TJ, et al. Williams: Hematology. 7th ed. New York, NY: McGraw Hill; 2006.
12. Handin RI, Lux IV SE, Stossel TP, eds. Blood: Principles and Practice of Hematology. 2nd ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2003.
13. Rodgers GP, Young NS, eds. Bethesda Handbook of Clinical Hematology. Philadelphia, PA: Lippincott Williams & Wilkins; 2005.
14. Boyiadzis MM, Lebowitz PF, Frame JN, Fojo T, eds. Hematology and Oncology Therapy. New York, NY: McGraw Hill; 2007.
15. Young NS, Gerson SL, High KA, eds. Clinical Hematology. Philadelphia, PA: Mosby Elsevier; 2006.
16. Hillman RS, Ault KA, Rinder HM. Hematology in Clinical Practice. 4th ed. New York, NY: McGraw Hill; 2005.
17. Hoffbrand AV, Catovsky D, Tuddenham EGD, eds. Postgraduate Haematology. 5th ed. Malden, MA: Blackwell Publishing; 2005.
18. Marx JA, ed. Rosen's Emergency Medicine: Concepts and Clinical Practice. 6th ed. St Louis, MO: Mosby; 2006.
19. Tintinalli JE, ed. Emergency Medicine: A Comprehensive Study Guide. 6th ed. New York, NY: McGraw Hill; 2004.
20. Wolfson AB, ed. Harwood-Nuss' Clinical Practice of Emergency Medicine. 4th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2005.
21. Warrell DA, Cox TM, Firth JD, Benz Jr ED, Weatherall DJ, eds. Oxford Textbook of Medicine. 4th ed. Oxford, United Kingdom: Oxford University Press; 2003.
22. Goldman L, Ausiello D, eds. Cecil: Textbook of Medicine. 22nd ed. Philadelphia, PA: Saunders; 2004.
23. Washington Manual of Medical Therapeutics. 31st ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2004.
24. Dale DD, ed. ACP Medicine On-Line. www. acpmedicine.com/cgi.bin/ publiccgi.pl?loginOP. Accessed October 31, 2006.
25. Kasper DL, Braunwald E, Fauci AS, et al. Harrison's: Principles of Internal Medicine. 16th ed. New York, NY: McGraw Hill; 2005.
26. Rakel E, ed. Conn's Current Therapy. 58th ed. Philadelphia, PA: Saunders; 2006.
27. Rose BD, Rush JM, founders. Up-To-Date Online, 2005. Accessed October 31, 2006. www. uptodateonline.com/utd/index.do.
28. Grahmann PH, Jackson KC, Lipman AG. Clinician beliefs about opioid use and barriers in chronic nonmalignant pain. J Pain Palliative Care Pharmacother. 2004;18:7-28.
29. Labbe E, Herbert D, Haynes J. Physicians' attitude and practices in sickle cell disease pain management. J Palliative Care. 2005;21:246-251.
30. ACC/AHA guidelines for the management of patients with acute myocardial infarction: a report of the American College of Cardiology/American Heart Association Taskforce on Practice Guidelines (Committee on Management of Acute Myocardial Infarction. TJ Ryan, Chairman). J Am Col Cardiol. 1996;28:1328-1428.
31. Gonzalez ER, Bahal N, Hansen LA, et al. Intermittant injection vs patient-controlled analgesia for sickle cell pain. Arch Intern Med. 1991;151:1373-1377.
32. Roy JD, Massicotte L, Sassine MP, Seal RF, Roy A. A comparison of intrathecal fentanyl/morphine and patient-controlled analgesia with patient-controlled analgesia alone after liver resection. Anesth Analg. 2006;103:990-994.
33. Jarvey KB, Ussery TW, Steger HG, Colclough GW. Comparison of morphine and morphine with ketamine for postoperative analgesia. Can J Anesth. 1996;43:212-215.
34. Gan TJ, Ginsberg B, Glass PS, Fortney J, Jhaveri R, Perno R. Opioid-sparing effects of a low-dose infusion of naloxone in patients administered morphine sulfate. Anesthesiology. 1997;87:1075-1081.
35. Bell EA, Jones BJ, Olufolabi AJ, et al. Iliohypogastric-ilioinguinal peripheral nerve block for post-Caesarian delivery analgesia decreases morphine use but not opioid-related side effects. Can J Anest. 2002;49:694-700.
36. Loper KA, Ready LB. Epidural morphine after anterior cruciate ligament repair: a comparison with patient-controlled intravenous morphine. Anesth Analg. 1989;68:350-352.
37. Dampier CD, Setty BNY, Logan J, Ioli JG, Dean R. Intravenous morphine pharmokinetics in pediatric patients with sickle cell disease. J Pediatrics. 1995;126:461-467.
38. Nagar S, Remmel RP, Hebbel RP, Zimmerman CL. Metabolism of opioids is altered in liver microsomes of sickle cell transgenic mice. Drug Metab Dispos. 2004;32:98-104.
39. Koppert W. Opioid-induced hyperalgesia: pathophysiology and clinical relevance. Acute Pain. 2007;9:21-34.
40. Grossman SA, Sheidler VR, Swedeen K, Mucenski J, Piantodosi S. Correlation of patient and caregiver ratings of cancer pain. J Pain Symptom Manage. 1991;6:53-57.
41. Waldrop RD, Mandry C. Health professional perceptions of opioid dependence among patients with pain. Am J Emerg Med. 1995;13:529-531.
42. Shapiro BS, Benjamin LJ, Payne R, Heidrich G. Sickle cell-related pain: perceptions of medical practitioners. J Pain Symptom Manage. 1997;14:168-174.
43. Pack-Mabien A, Labbe E, Herbert D, Haynes Jr J. Nurses' attitudes and practices in sickle cell pain management. Appl Nursing Res. 2001;14:187-192.
44. Payne R. Pain management in sickle cell disease: rationale and techniques. Ann NY Acad Sci. 1989;565:189-206.
45. Brookoff D, Polomano R. Treating sickle cell pain like cancer pain. Ann Intern Med. 1992;116:364-368.
46. Okpala I, Tawil A. Management of pain in sickle-cell disease. J R Soc Med. 2002;95:456-458.
47. Robins LN, Helzer JE, Weissman MM, et al. Lifetime prevalence of specific psychiatric disorders in 3 sites. Arch Gen Psychiatry. 1984;41:949-958.
48. Wright D, Sathe N, Spagnola K. State estimates of substance use from the 2004-2005 national surveys on drug use and health. http://www.samhsa.gov. 2007;168-170.
49. Savage SR. Assessment of addiction in pain-treatment settings. Clin J Pain. 2002;18:S28-S38.
50. Elander J, Lusher J, Bevan D, Telfer P, Burton B. Understanding the causes of problematic pain management in sickle cell disease: evidence that pseudoaddiction plays a more important role than genuine analgesic dependence. J Pain Symptom Manage. 2004;27:156-169.
51. Green CR, Anderson KO, Baker TA, et al. The unequal burden of pain: confronting racial and ethnic disparities in pain. Pain Med. 2003;4:277-294.
52. Ballas SK. Ethical issues in the management of sickle cell pain. Am J Hematol. 2001;68:127-132.
53. Medline/Pubmed at the United States National Library of Medicine, National Institutes of Health. www.nlm.nih.gov/portals/healthcare.html.
54. Benjamin LJ, Swinson GI, Nagel RL. Sickle cell anemia day hospital: an approach for the management of uncomplicated pain crisis. Blood. 2000;95:1130-1137.
55. Wright J, Bareford D, Wright C, et al. Day case management of sickle pain: 3 years experience in a UK sickle cell unit. Br J Haematol. 2004;126:878-880.
56. Givens M, Rutherford C, Joshi G, Delaney K. Impact of an emergency department pain management protocol on the pattern of visits of patients with sickle cell disease. J Emerg Med. 2007;32:239-243.
57. Bijur PE, Kenny MK, Gallagher EJ. Intravenous morphine at 0.1 mg/kg is not effective for controlling severe acute pain in the majority of patients. Ann Emerg Med. 2005;46:362-367.
58. Ballas SK. Sickle Cell Pain: Progress in Pain Research and Management. Vol 11. Seattle, WA: IASP Press; 1998.
59. Benjamin L. Nature and treatment of the acute painful episodes in sickle cell disease. In: Steinberg MH, Forget BG, Higgs DR, Nagel RL, eds. Disorders of Hemoglobin: Genetics, Pathophysiology and Clinical Management. Cambridge, United Kingdom: Cambridge University Press; 2001:671-710.
60. Telfair J, Haque A, Ettenne M, Tang S, Strasser S. Rural/urban differences in access to and utilization of services among people in Alabama with sickle cell disease. Public Health Rep. 2003;118:27-36.
61. Dunlop RJ, Bennett KC. Pain management for sickle cell disease (Review). The Cochrane Library. 2006;4:1-22. (Cochrane Database of Systemic Reviews (2):CD003350, 2006).
62. Solomon LR. Treatment of pain due to vaso-occlusive crisis in adults with sickle cell disease: limited awareness of available guidelines. Blood. 2006;108: Abstract 3357.